Gi Hoon Son

Prof. Gi Hoon Son

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2014 in Cell
Verified
Journal Article
Closed access
SCSooyoung Chung
Sooyoung Chung
ELEun Jeong Lee
Eun Jeong Lee
SYSeongsik Yun
Seongsik Yun
HCHan Kyoung Choe
Han Kyoung Choe
SPSeong-Beom Park
Seong-Beom Park
KKKyungjin Kim
Kyungjin Kim

6 April 2018 in Journal of the Endocrine Society
Verified
Journal Article
Open access
PDF file
GSGi Hoon Son
Gi Hoon Son
HCHyo Kyeong Cha
Hyo Kyeong Cha
SCSooyoung Chung
Sooyoung Chung
KKKyungjin Kim
Kyungjin Kim
Adrenal glucocorticoids (GCs) control a wide range of physiological processes, including metabolism, cardiovascular and pulmonary activities, immune and inflammatory responses, and various brain functions. During stress responses, GCs are secreted through activation of the hypothalamic–pituitary–adrenal axis, whereas circulating GC levels in unstressed states follow a robust circadian oscillation with a peak around the onset of the active period of a day. A recent advance in chronobiological research has revealed that multiple regulatory mechanisms, along with classical neuroendocrine regulation, underlie this GC circadian rhythm. The hierarchically organized circadian system, with a central pacemaker in the suprachiasmatic nucleus of the hypothalamus and local oscillators in peripheral tissues, including the adrenal gland, mediates periodicities in physiological processes in mammals. In this review, we primarily focus on our understanding of the circadian regulation of adrenal GC rhythm, with particular attention to the cooperative actions of the suprachiasmatic nucleus central and adrenal local clocks, and the clinical implications of this rhythm in human diseases.

12 April 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SCSooyoung Chung
Sooyoung Chung
ELEun Jeong Lee
Eun Jeong Lee
HCHyo Kyeong Cha
Hyo Kyeong Cha
JKJeongah Kim
Jeongah Kim
DKDoyeon Kim
Doyeon Kim
KKKyungjin Kim
Kyungjin Kim
The mammalian circadian timing system consists of the central clock in the hypothalamic suprachiasmatic nucleus (SCN) and subsidiary peripheral clocks in other tissues. Glucocorticoids (GCs) are adrenal steroid hormones with widespread physiological effects that undergo daily oscillations. We previously demonstrated that the adrenal peripheral clock plays a pivotal role in circadian GC rhythm by driving cyclic GC biosynthesis. Here, we show that the daily rhythm in circulating GC levels is controlled by bimodal actions of central and adrenal clockwork. When mice were subjected to daytime restricted feeding to uncouple central and peripheral rhythms, adrenal GC contents and steroidogenic acute regulatory protein expression peaked around zeitgeber time 00 (ZT00), consistent with shifted adrenal clock gene expression. However, restricted feeding produced two distinct peaks in plasma GC levels: one related to adrenal GC content and the other around ZT12, which required an intact SCN. Light pulse-evoked activation of the SCN increased circulating GC levels in both wild-type and adrenal clock-disrupted mutant mice without marked induction of GC biosynthesis. In conclusion, we demonstrate that adrenal clock-dependent steroidogenesis and a SCN-driven central mechanism regulating GC release cooperate to produce daily circulatory GC rhythm.

21 January 2019 in Frontiers in Molecular Neuroscience
Verified
Journal Article
Open access
PDF file
HCHyo Kyeong Cha
Hyo Kyeong Cha
SCSooyoung Chung
Sooyoung Chung
HLHye Young Lim
Hye Young Lim
JJJong-Wha Jung
Jong-Wha Jung
GSGi Hoon Son
Gi Hoon Son
Circadian rhythms regulate many biological processes and play fundamental roles in behavior, physiology, and metabolism. Such periodicity is critical for homeostasis because disruption or misalignment of the intrinsic rhythms is associated with the onset and progression of various human diseases and often directly leads to pathological states. Since the first identification of mammalian circadian clock genes, numerous genetic and biochemical studies have revealed the molecular basis of these cell-autonomous and self-sustainable rhythms. Specifically, these rhythms are generated by two interlocking transcription/translation feedback loops of clock proteins. As our understanding of these underlying mechanisms and their functional outputs has expanded, strategies have emerged to pharmacologically control the circadian molecular clock. Small molecules that target the molecular clock may present novel therapeutic strategies to treat chronic circadian rhythm-related diseases. These pharmaceutical approaches may include the development of new drugs to treat circadian clock-related disorders or combinational use with existing therapeutic strategies to improve efficacy via intrinsic clock-dependent mechanisms. Importantly, circadian rhythm disruptions correlate with, and often precede, many symptoms of various neuropsychiatric disorders such as sleep disorders, affective disorders, addiction-related disorders, and neurodegeneration. In this mini-review, we focus on recent discoveries of small molecules that pharmacologically modulate the core components of the circadian clock and their potential as preventive and/or therapeutic strategies for circadian clock-related neuropsychiatric diseases.

17 January 2023 in Laboratory Investigation
Verified
Journal Article
Closed access
YFYina Fang
Yina Fang
SJSang-Kyung Jo
Sang-Kyung Jo
SPSoo-Ji Park
Soo-Ji Park
JYJihyun Yang
Jihyun Yang
YKYoon Sook Ko
Yoon Sook Ko
MKMyung-Gyu Kim
Myung-Gyu Kim

8 April 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
JPJae Woo Park
Jae Woo Park
EREun Roh
Eun Roh
GKGil Myoung Kang
Gil Myoung Kang
SGSo Young Gil
So Young Gil
HKHyun Kyong Kim
Hyun Kyong Kim
MKMin-Seon Kim
Min-Seon Kim
Nicotinamide adenine dinucleotide (NAD+) is an essential cofactor of critical enzymes including protein deacetylase sirtuins/SIRTs and its levels in mammalian cells rely on the nicotinamide phosphoribosyltransferase (NAMPT)-mediated salvage pathway. Intracellular NAMPT (iNAMPT) is secreted and found in the blood as extracellular NAMPT (eNAMPT). In the liver, the iNAMPT−NAD+ axis oscillates in a circadian manner and regulates the cellular clockwork. Here we show that the hypothalamic NAD+ levels show a distinct circadian fluctuation with a nocturnal rise in lean mice. This rhythm is in phase with that of plasma eNAMPT levels but not with that of hypothalamic iNAMPT levels. Chemical and genetic blockade of eNAMPT profoundly inhibit the nighttime elevations in hypothalamic NAD+ levels as well as those in locomotor activity (LMA) and energy expenditure (EE). Conversely, elevation of plasma eNAMPT by NAMPT administration increases hypothalamic NAD+ levels and stimulates LMA and EE via the hypothalamic NAD+−SIRT−FOXO1−melanocortin pathway. Notably, obese animals display a markedly blunted circadian oscillation in blood eNAMPT−hypothalamic NAD+−FOXO1 axis as well as LMA and EE. Our findings indicate that the eNAMPT regulation of hypothalamic NAD+ biosynthesis underlies circadian physiology and that this system can be significantly disrupted by obesity.